Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
142M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
115M
-
Shares change
-
+2.01M
-
Total reported value, excl. options
-
$98.5M
-
Value change
-
-$63M
-
Put/Call ratio
-
0.73
-
Number of buys
-
76
-
Number of sells
-
-70
-
Price
-
$0.86
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q4 2024
180 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q4 2024.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 115M shares
of 142M outstanding shares and own 81.29% of the company stock.
Largest 10 shareholders include Vestal Point Capital, LP (11.5M shares), VR Adviser, LLC (9.99M shares), Propel Bio Management, LLC (9.62M shares), BlackRock, Inc. (9.3M shares), MORGAN STANLEY (8.82M shares), Schonfeld Strategic Advisors LLC (8.76M shares), Knoll Capital Management, LLC (5.8M shares), VANGUARD GROUP INC (5.55M shares), T. Rowe Price Investment Management, Inc. (5.42M shares), and DEUTSCHE BANK AG\ (4.47M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.